If you're looking for an easy way to invest your hard-earned money, then exchange traded funds (ETFs) could be the answer.
That's because ETFs give you the opportunity to invest in a large group of shares in one fell swoop, which can be a great way to build a diverse portfolio.
But which ETFs should you look at this month? Here are two popular ETFs that could be quality options right now:
BetaShares NASDAQ 100 ETF (ASX: NDQ)
The BetaShares NASDAQ 100 ETF could be worth considering in October. Particularly given its incredibly poor showing during September, which has left it trading around its lowest levels of the year.
This ETF provides investors with access to the top 100 non-financial shares on the famous NASDAQ stock exchange. This includes the likes of Alphabet, Amazon, Apple, Meta, Microsoft, Netflix, Nvidia, and Tesla.
BetaShares also highlights that with a strong focus on technology, the ETF provides investors with diversified exposure to a high-growth potential sector that is under-represented on the Australian share market.
ETFS S&P Biotech ETF (ASX: CURE)
Another ETF for investors to consider in October is the ETFS S&P Biotech ETF.
This ETF gives investors exposure to the U.S. biotechnology sector. ETFS notes that these are companies that are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.
Among its holdings you will find the likes of ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.
A big fan of the ETF is Felicity Thomas from Shaw & Partners. She recently told Livewire:
I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.
